Cargando…
Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
BACKGROUND: In the post-Z0011 trial era, the need to perform surgical axillary staging for early-stage breast cancer patients, who are treated with breast-conserving therapy (BCT), is being questioned. We conducted a retrospective cohort study using the Surveillance, Epidemiology, and End Results (S...
Autores principales: | Wang, Jin, Tang, Hailin, Li, Xing, Song, Cailu, Xiong, Zhenchong, Wang, Xi, Xie, Xiaoming, Tang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505128/ https://www.ncbi.nlm.nih.gov/pubmed/31068224 http://dx.doi.org/10.1186/s40880-019-0371-y |
Ejemplares similares
-
Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer
por: Xie, Xinhua, et al.
Publicado: (2019) -
Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer
por: Xie, Xinhua, et al.
Publicado: (2018) -
miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer
por: Wang, Jin, et al.
Publicado: (2017) -
Could local surgery improve survival in de novo stage IV breast cancer?
por: Xiong, Zhenchong, et al.
Publicado: (2018) -
High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer
por: Song, Cailu, et al.
Publicado: (2016)